Evidence map›Paper›PMID 32142826›Full record

SynthesisAmerican journal of obstetrics and gynecology2020

Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and intrauterine device type: a systematic review and meta-analysis.

Sarah H Averbach, Yokabed Ermias, Gary Jeng, Kathryn M Curtis, Maura K Whiteman, Erin Berry-Bibee, Denise J Jamieson, Polly A Marchbanks, Naomi K Tepper, Tara C Jatlaoui

Registry-linked trialOpen access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in American journal of obstetrics and gynecology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05624411 (Clinical Outcomes of Post-placental Insertion of Cupper T380A and Multiload 375 Contraceptive Devices During Cesarean Section), which is not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05624411 unknown statusnot on this mapstarted 2022, after this paper: background citation

Clinical Outcomes of Post-placental Insertion of Cupper T380A and Multiload 375 Contraceptive Devices During Cesarean Section

TypeobservationalSponsorSohag UniversityRan2022 to 2023Enrolled150ConditionsIUD (Intrauterine Device) Malposition, IUD, Complications, Infection or InflammationArmsCU T380A IUD, multiload 375 IUD
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Manual versus forceps postplacental IUD insertion after vaginal delivery: A randomized clinical trial.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Trial
  4. Trial
  5. Trial
  6. Association of novel intra-cesarean post-placental intrauterine device insertion techniques, and early ultrasound, with expulsion rates and strings visibility: A prospective exploratory study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Observational
  7. Review
  8. Post-pregnancy contraception.Reproduction & fertility · 2026
    Review
  9. Incidence and risk factors for postplacental intrauterine device expulsion in a Brazilian hospital.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sarah H AverbachDepartment of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of California San Diego, San Diego, CA. Electronic address: saverbach@ucsd.edu.
Yokabed ErmiasSchool of Medicine, University of California San Diego, San Diego, CA.
Gary JengDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Kathryn M CurtisDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Maura K WhitemanDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Erin Berry-BibeeDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Denise J JamiesonDepartment of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA.
Polly A MarchbanksDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Naomi K TepperDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Tara C JatlaouiDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Centers for Disease Control and Prevention · USUniversity of California San Diego · USEmory University · US

Funding

UC San Diego Womens Reproductive Health Research ProgramK12HD001259 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CYNTHIA GYAMFI-BANNERMAN · 1999 to 2026
$9.1M
NICHD NIH HHS K12 HD001259
6 · The paper itself

Abstract

objectivesTo provide updated and more detailed pooled intrauterine device expulsion rates and expulsion risk estimates among women with postpartum intrauterine device placement by timing of insertion, delivery type, and intrauterine device type to inform current intrauterine device insertion practices in the United States. DATA SOURCES: We searched PubMed, Cochrane Library, and ClinicalTrials.gov through June 2019. STUDY ELIGIBILITY CRITERIA: We included all studies, of any study design, that examined postpartum placement of Copper T380A (copper) or levonorgestrel-containing intrauterine devices that reported counts of expulsion. STUDY APPRAISAL AND SYNTHESIS

methodsWe evaluated intrauterine device expulsion among women receiving postpartum intrauterine devices in the "immediate" (within 10 minutes), "early inpatient" (>10 minutes to <72 hours), "early outpatient" (72 hours to <4 weeks), and interval (≥4 weeks) time periods after delivery. We assessed study quality using the US Preventive Services Task Force evidence grading system. We calculated pooled absolute rates of partial and complete intrauterine device expulsion separately and estimated adjusted relative risks by the timing of postpartum placement, delivery type, and intrauterine device type using log-binomial multivariable regression.

resultsWe identified 48 level I to II-3 studies of poor to good quality that reported a total of 7661 intrauterine device placements. Complete intrauterine device expulsion rates varied by timing of placement as follows: 10.2% (range, 0.0-26.7) for immediate; 13.2% (3.5-46.7) for early inpatient; 0% for early outpatient; and 1.8% (0.0-4.8) for interval placements. Complete intrauterine device expulsion rates also varied by delivery type: 14.8% (range, 4.8-43.1) for vaginal and 3.8% (0.0-21.1) for cesarean deliveries. Among immediate postpartum vaginal placements, the expulsion rate for levonorgetrel intrauterine devices was 27.4% (range, 18.8-45.2) and 12.4% (4.8-43.1) for copper intrauterine devices. Compared with interval placement, immediate and early postpartum placements (inpatient and outpatient combined) were associated with greater risk of complete expulsion (adjusted risk ratio, 8.33; 95% confidence interval, 4.32-16.08, and adjusted risk ratio, 5.27; 95% confidence interval, 2.56-10.85, respectively). Among immediate postpartum placements, risk of expulsion was greater for placement after vaginal compared with cesarean deliveries (adjusted risk ratio, 4.57; 95% confidence interval, 3.49-5.99). Among immediate placements at the time of vaginal delivery, levonorgestrel intrauterine devices were associated with a greater risk of expulsion compared with copper intrauterine devices (adjusted risk ratio, 1.90; 95% confidence interval, 1.36-2.65).

conclusionAlthough intrauterine device expulsion rates vary by timing of placement, type, and mode of delivery, intrauterine device insertion can take place at any time. Understanding the risk of intrauterine device expulsion at each time period will enable women to make an informed choice about when to initiate use of an intrauterine device in the postpartum period based on their own goals and preferences.

Indexed as

Delivery, ObstetricIntrauterine Device ExpulsionIntrauterine DevicesFemaleHumansPostpartum PeriodPregnancyRisk FactorsTime FactorscontraceptioncopperdeliveryearlyexpulsionimmediateintervalIUDlevonorgestrelpostpartum

Identifiers

PMID32142826
PMCPMC7395881
OpenAlexW3009637989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.